SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,000 | -62.5% | 111 | -62.1% | 0.00% | – |
| Q3 2021 | $8,000 | -100.0% | 293 | -99.9% | 0.00% | -100.0% |
| Q2 2021 | $16,080,000 | +92.7% | 522,260 | +63.9% | 0.10% | +76.3% |
| Q1 2021 | $8,344,000 | -74.5% | 318,706 | -75.5% | 0.06% | -80.5% |
| Q4 2020 | $32,759,000 | +59.8% | 1,302,015 | +32.4% | 0.30% | +17.0% |
| Q3 2020 | $20,494,000 | -9.8% | 983,395 | +2.8% | 0.26% | -13.1% |
| Q2 2020 | $22,727,000 | +152.0% | 956,924 | +90.9% | 0.30% | +96.1% |
| Q1 2020 | $9,020,000 | -26.8% | 501,392 | -3.4% | 0.15% | +10.9% |
| Q4 2019 | $12,317,000 | -46.1% | 519,271 | -37.6% | 0.14% | -49.4% |
| Q3 2019 | $22,870,000 | +329.2% | 832,247 | +416.7% | 0.27% | +337.1% |
| Q2 2019 | $5,329,000 | +177533.3% | 161,057 | +101834.8% | 0.06% | – |
| Q2 2015 | $3,000 | – | 158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |